Annual ROE
-88.58%
+8.56%+8.81%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual return on equity is -88.58%, with the most recent change of +8.56% (+8.81%) on June 1, 2024.
- During the last 3 years, NEUP annual ROE has fallen by -59.20% (-201.50%).
Performance
NEUP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-17.07%
+12.52%+42.31%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly return on equity is -17.07%, with the most recent change of +12.52% (+42.31%) on December 1, 2024.
- Over the past year, NEUP quarterly ROE has stayed the same.
Performance
NEUP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NEUP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.8% | 0.0% |
| 3 y3 years | -201.5% | +15.0% |
| 5 y5 years | -62.5% | - |
NEUP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +201.5% | +9.7% | at high | +215.2% |
| 5 y | 5-year | +201.5% | +9.7% | at high | +215.2% |
| alltime | all time | -243.2% | +9.7% | at high | +215.2% |
Neuphoria Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -17.07%(-42.3%) |
| Sep 2024 | - | -29.59%(-45.0%) |
| Jun 2024 | - | -53.81%(+12.1%) |
| Jun 2024 | -88.58%(-8.8%) | - |
| Dec 2023 | - | -47.99%(+138.9%) |
| Sep 2023 | - | -20.09% |
| Jun 2023 | -97.14%(+143.1%) | - |
| Jun 2022 | -39.96%(+36.0%) | - |
| Jun 2021 | -29.38%(-36.6%) | - |
| Jun 2020 | -46.34%(-15.0%) | - |
| Jun 2019 | -54.50%(-35.6%) | - |
| Jun 2018 | -84.64%(+412.3%) | - |
| Jun 2017 | -16.52%(-62.6%) | - |
| Jun 2016 | -44.13%(+13.2%) | - |
| Jun 2015 | -38.97%(-616.2%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | 7.55%(-126.6%) | - |
| Jun 2013 | -28.39%(+152.8%) | - |
| Jun 2012 | -11.23%(-70.6%) | - |
| Jun 2011 | -38.23%(+0.6%) | - |
| Jun 2010 | -38.01%(+22.5%) | - |
| Jun 2009 | -31.04%(+35.1%) | - |
| Jun 2008 | -22.97%(-32.0%) | - |
| Jun 2007 | -33.77%(-31.4%) | - |
| Jun 2006 | -49.24%(+0.3%) | - |
| Jun 2005 | -49.10%(+5.8%) | - |
| Jun 2004 | -46.42%(-23.0%) | - |
| Jun 2003 | -60.30%(+66.1%) | - |
| Jun 2002 | -36.31%(+12.8%) | - |
| Jun 2001 | -32.19%(+14.8%) | - |
| Jun 2000 | -28.03%(-145.3%) | - |
| Jun 1999 | 61.85% | - |
FAQ
- What is Neuphoria Therapeutics annual return on equity?
- What is the all time high annual ROE for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual ROE year-on-year change?
- What is Neuphoria Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly ROE year-on-year change?
What is Neuphoria Therapeutics annual return on equity?
The current annual ROE of NEUP is -88.58%
What is the all time high annual ROE for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual return on equity is 61.85%
What is Neuphoria Therapeutics annual ROE year-on-year change?
Over the past year, NEUP annual return on equity has changed by +8.56% (+8.81%)
What is Neuphoria Therapeutics quarterly return on equity?
The current quarterly ROE of NEUP is -17.07%
What is the all time high quarterly ROE for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly return on equity is -17.07%
What is Neuphoria Therapeutics quarterly ROE year-on-year change?
Over the past year, NEUP quarterly return on equity has changed by 0.00% (0.00%)